Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Infectious Disease
Is there any evidence that TNF inhibitors alter immunogenicity of vaccines?
If so, does delaying/skipping a dose improve immunogenicity?
Related Questions
Do you recommend chronic oral suppressive antibiotics after initial intensive treatment of 6-8 weeks in patients with culture-negative prosthetic joint or bone infections with retained hardware?
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
Is there any role for administering another course of recombinant zoster vaccine (Shingrix) in a previously vaccinated patient with RA, who is in clinical remission on JAK inhibitor but has had a breakthrough shingles infection?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
How often do you see bony erosions in patients with Lyme arthritis?
How do you approach the management of digital ischemia in a critically ill patient with infection, but no evidence of active rheumatologic disease?